Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Archives

Plasma protein binding: Important, needed, non-optimisable

Dr Richard Weaver, Senior Vice President of Preclinical Development at Sygnature Discovery, shares his thoughts on the role of plasma...
View Article